Lupin Acquires Huminsulin from Eli Lilly to Strengthen Diabetes Care Portfolio in India
Global pharmaceutical company Lupin has announced the acquisition of the Huminsulin brand in India from Eli Lilly and Company. This…
Huminsulin
Read More
December 8, 2025
- ASG Eye Hospital to invest ₹2,000 crore to boost Nationwide Eye Care Access
- Gates Foundation Grants ₹1.3 Crore to Gujarat Biotechnology University for Pioneering Women’s Health Research
- Novo Nordisk to Introduce Ozempic in India This Month
- Uranium Traces Found in Breastmilk Across Bihar; Researchers Flag Possible Infant Health Risks